Prulifloxacin ECG study

Clin Drug Investig. 2010;30(4):275-7. doi: 10.2165/11311700-000000000-00000.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Aza Compounds / administration & dosage
  • Aza Compounds / adverse effects
  • Clinical Trials as Topic / methods
  • Dioxolanes / administration & dosage
  • Dioxolanes / adverse effects*
  • Electrocardiography / methods
  • Fluoroquinolones / administration & dosage
  • Fluoroquinolones / adverse effects*
  • Humans
  • Moxifloxacin
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Quinolines / administration & dosage
  • Quinolines / adverse effects

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Dioxolanes
  • Fluoroquinolones
  • Piperazines
  • Quinolines
  • prulifloxacin
  • Moxifloxacin